silicon carbide has been researched along with indomethacin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crijns, HJ; de Kam, PJ; Monnink, SH; Peels, HO; Tigchelaar, I; van Boven, AJ; van Oeveren, W | 1 |
Díaz-Rodríguez, P; Landin, M | 1 |
2 other study(ies) available for silicon carbide and indomethacin
Article | Year |
---|---|
Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
Topics: Blood Platelets; Carbon Compounds, Inorganic; Cell Adhesion; Coated Materials, Biocompatible; Coronary Vessels; Humans; In Vitro Techniques; Indomethacin; Leukocytes; Platelet Activation; Prosthesis Design; Silicon Compounds; Stainless Steel; Stents; Tantalum; Thrombosis | 1999 |
Controlled release of indomethacin from alginate-poloxamer-silicon carbide composites decrease in-vitro inflammation.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Compounds, Inorganic; Cell Line; Ceramics; Chondrocytes; Collagen; Cytokines; Delayed-Action Preparations; Drug Liberation; Extracellular Matrix; Glucuronic Acid; Hexuronic Acids; Humans; Indomethacin; Inflammation; Macrophages; Mice; Osteoarthritis; Poloxamer; Silicon Compounds; Solubility | 2015 |